# A First in Human Study for the Versa Device for Tricuspid Regurgitation

> **NCT06368401** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Versa Vascular, Inc** · enrollment: 10 (estimated)

## Conditions studied

- Tricuspid Regurgitation

## Interventions

- **DEVICE:** Versa Implant

## Key facts

- **NCT ID:** NCT06368401
- **Lead sponsor:** Versa Vascular, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-05
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-10-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06368401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06368401, "A First in Human Study for the Versa Device for Tricuspid Regurgitation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06368401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*